Table 1.

Historical data

UPNSexAge at study entry (y, m)Prior cytokine therapySevere neutropeniaKnown neutrophil dysfunctionIV antibiotic therapy
21 5y 8m yes yes yes yes 
22 8m yes N/A yes no 
23 23y 10m no yes yes yes 
24 9y 2m no yes no yes 
25 8y 2m yes yes yes yes 
26 8m no yes no yes 
27 5y 0m yes yes no yes 
28 10y 8m yes yes no yes 
31 16y 1m yes yes yes yes 
32 9y 10m no yes yes yes 
33 6y 7m no yes no yes 
34 20y 11m no yes no no 
35 13y 1m no yes no yes 
UPNSexAge at study entry (y, m)Prior cytokine therapySevere neutropeniaKnown neutrophil dysfunctionIV antibiotic therapy
21 5y 8m yes yes yes yes 
22 8m yes N/A yes no 
23 23y 10m no yes yes yes 
24 9y 2m no yes no yes 
25 8y 2m yes yes yes yes 
26 8m no yes no yes 
27 5y 0m yes yes no yes 
28 10y 8m yes yes no yes 
31 16y 1m yes yes yes yes 
32 9y 10m no yes yes yes 
33 6y 7m no yes no yes 
34 20y 11m no yes no no 
35 13y 1m no yes no yes 

Historical data were obtained by review of patients' medical records. Prior cytokine therapy indicates any cytokine therapy given at any time prior to study enrollment. Severe neutropenia indicates ANC < 0.5 × 109 cells/L on 3 separate occasions at least one month prior to initiation of cytokine therapy. Known neutrophil dysfunction indicates that the patient had at least one abnormality in neutrophil function which was documented by laboratory assessment prior to study enrollment. IV antibiotic therapy indicates any hospital admission for IV antibiotic therapy for proven or suspected infection within the 12 months prior to initiation of any cytokine therapy. N/A indicates not available.

or Create an Account

Close Modal
Close Modal